Search hospitals > California > Sacramento
University of California, Davis, Medical Center
Claim this profileSacramento, California 95817
Global Leader in Muscular Dystrophy
Global Leader in High Blood Pressure
Conducts research for Pulmonary Hypertension
Conducts research for Duchenne Muscular Dystrophy
Conducts research for Fibrosis
1080 reported clinical trials
94 medical researchers
Summary
University of California, Davis, Medical Center is a medical facility located in Sacramento, California. This center is recognized for care of Muscular Dystrophy, High Blood Pressure, Pulmonary Hypertension, Duchenne Muscular Dystrophy, Fibrosis and other specialties. University of California, Davis, Medical Center is involved with conducting 1,080 clinical trials across 1,007 conditions. There are 94 research doctors associated with this hospital, such as Edward J. Kim, Joseph M. Tuscano, Jonathan W. Riess, and Mamta Parikh.Area of expertise
1Muscular Dystrophy
Global LeaderDMD positive
dystrophin positive
DMD negative
2High Blood Pressure
Global Leader6MWD
CTD-ILD
Top PIs
Edward J. KimUniversity of California Davis Comprehensive Cancer Center1 year of reported clinical research
Studies Cancer
Studies Adenocarcinoma
30 reported clinical trials
68 drugs studied
Joseph M. TuscanoUniversity of California Davis Comprehensive Cancer Center5 years of reported clinical research
Expert in Lymphoma
Studies B-Cell Lymphoma
19 reported clinical trials
37 drugs studied
Jonathan W. RiessUniversity of California Davis Comprehensive Cancer Center4 years of reported clinical research
Expert in Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
30 drugs studied
Mamta ParikhUniversity of California Davis Comprehensive Cancer Center8 years of reported clinical research
Expert in Cancer
Studies Bladder Cancer
21 reported clinical trials
36 drugs studied
Clinical Trials running at University of California, Davis, Medical Center
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Bladder Cancer
Breast Cancer
Age-Related Macular Degeneration
Osteoarthritis
Parkinson's Disease
Head and Neck Cancers
Cancer
Prostate Cancer
Disitamab Vedotin
for HER2-Positive Cancer
This trial is testing a new drug called disitamab vedotin (DV) on patients with advanced or metastatic cancers that have a specific marker called HER2. The drug works by finding and attaching to cancer cells, then delivering a substance to kill them. The study aims to see if DV is effective and safe for these patients. Disitamab vedotin is an antibody-drug conjugate designed for targeting HER2 that has been approved for urothelial carcinoma and gastric cancer.
Recruiting1 award Phase 2
Tisotumab Vedotin
for Cancer
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects (unwanted effects) may occur. There are seven parts to this study. * In Part A, the treatment will be given to participants every 3 weeks (3-week cycles). * In Part B, participants will receive tisotumab vedotin on Days 1, 8, and 15 every 4-week cycle. * In Part C, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part D, participants will be given treatment on Day 1 of every 3-week cycle. Participants in Part D will get tisotumab vedotin with either: * Pembrolizumab or, * Pembrolizumab and carboplatin, or * Pembrolizumab and cisplatin * In Part E, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part F, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part F will get tisotumab vedotin with pembrolizumab. * In Part G, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part G will get tisotumab vedotin with pembrolizumab and carboplatin.
Recruiting1 award Phase 216 criteria
SGN-PDL1V
for Cancer
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of California, Davis, Medical Center?
University of California, Davis, Medical Center is a medical facility located in Sacramento, California. This center is recognized for care of Muscular Dystrophy, High Blood Pressure, Pulmonary Hypertension, Duchenne Muscular Dystrophy, Fibrosis and other specialties. University of California, Davis, Medical Center is involved with conducting 1,080 clinical trials across 1,007 conditions. There are 94 research doctors associated with this hospital, such as Edward J. Kim, Joseph M. Tuscano, Jonathan W. Riess, and Mamta Parikh.
Where is University of California, Davis, Medical Center located?
**Directions to University of California, Davis Medical Center:**
- From I-80 West, exit onto Stockton Blvd and turn right.
- Turn left onto X Street to reach the hospital's main entrance.
Who should I call to ask about financial aid or insurance network?
**University of California, Davis Medical Center - Financial Assistance and Insurance Contact Information**
**Financial Assistance:**
- **Phone:** (916) 734-9200 or 1-800-551-9411 (Monday–Friday, 8:30 a.m. to 4:00 p.m.)
- **Hand-Delivery Address:** Financial Clearance Department, 4301 X St., Suite 1P214, Sacramento, CA 95817
- **Mailing Address:** UC Davis Health Patient Billing, Attn: FA Program, PO Box 168015, Sacramento, CA 95816-9979
**Insurance and Billing:**
- **Hospital Bill (Before Discharge):** Contact the Financial Clearance Department
- **Hospital Bill (After Discharge), Doctors’ Fees, or Outpatient Services Bill:** Contact Patient Billing Customer Service
- **Email:** hs-patientbilling@ucdavis.edu
For the financial assistance policy and application, visit the UC Davis Health website.
What insurance does University of California, Davis, Medical Center accept?
The University of California, Davis, Medical Center accepts a range of insurance plans, such as PPOs and standard plans from Aetna, Beech Street, Anthem Blue Cross, Blue Shield, Cigna, Health Net, UC Blue & Gold, and United Healthcare. Health Net's UC Blue & Gold HMO plan also provides access to UC Davis Medical Center and UC Davis Health primary care providers and specialists. It is recommended to confirm the acceptance of your specific insurance plan by directly contacting the facility or consulting with your insurance provider.
What awards or recognition has University of California, Davis, Medical Center received?
The University of California, Davis, Medical Center, located in Sacramento, California, is renowned for its groundbreaking research. In 2022, it achieved a new milestone by securing $1.07 billion in external research funding. Additionally, in 2023, the California Institute for Regenerative Medicine (CIRM) supported its stem-cell research projects with over $36 million.